Solubilisation of Bio-active Lipid Agents (BLA)
Technology
B-Organic has developed and patented a simple and natural matrix to be used as a unique innovative excipient which is able to enhance bioavailability of several poorly soluble drugs, fatty acids and vitamins and consequently to improve performance for numerous active pharmaceutical ingredients (APIs).
Applications
Pharmaceutical sector
There are multiple reasons for the pharmaceutical industry to consider the use of B-Organics innovative matrix:
-
By improving the absorption and the bio-availablity, the amount of active pharmaceutical ingredients (APIs) can be reduced, not only diminishing their costs, but also their adverse effects.
-
Since many approved APIs are approaching the end of their patent-life, it is possible to reformulate these APIs with B-Organic matrix to extend their patent-life.
Several formulation designs of API candidates were previously rejected due to their low solubility during phases of their development. Properly reformulated with B-Organic matrix, these API candidates can complete clinical trials and regulatory approval to make it in market.
